Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs4718429 | chr7:66421688 | G/C | 0.000217 | 178 | 24.7 | 29.57 | 33.17 | KM Plot |
PCPG | rs4726097 | chr7:151497968 | C/G | 9.7E-6 | 178 | 25.6 | 25.4 | 3.17 | KM Plot |
PCPG | rs4766327 | chr12:5110832 | C/T | 3.08E-5 | 178 | 25.4 | 24.23 | 14.4 | KM Plot |
PCPG | rs4766540 | chr12:111586426 | A/G | 2.46E-7 | 171 | 25.87 | 22.5 | 8.2 | KM Plot |
PCPG | rs478263 | chr3:80680042 | A/G | 0.000182 | 176 | 19.53 | 24.5 | 27.2 | KM Plot |
PCPG | rs4783145 | chr16:85227735 | C/G | 2.04E-7 | 170 | 25.92 | 21.95 | 17.43 | KM Plot |
PCPG | rs4785684 | chr16:89574576 | G/A | 0.000314 | 176 | 26.78 | 25.17 | 19.87 | KM Plot |
PCPG | rs4785685 | chr16:89578756 | C/G | 0.000207 | 176 | 26.78 | 25.28 | 19.53 | KM Plot |
PCPG | rs4785686 | chr16:89587871 | A/C | 0.000269 | 177 | 26.78 | 25.67 | 19.25 | KM Plot |
PCPG | rs4785688 | chr16:89595509 | C/T | 0.000362 | 176 | 27.6 | 25.28 | 19.2 | KM Plot |
PCPG | rs4785689 | chr16:89595516 | G/A | 0.000411 | 176 | 27.6 | 25.4 | 18.7 | KM Plot |
PCPG | rs4789695 | chr17:80473582 | C/T | 6.99E-5 | 171 | 25.77 | 22.83 | 7.2 | KM Plot |
PCPG | rs4789787 | chr17:80509786 | C/T | 4.17E-5 | 178 | 25.92 | 20.13 | 7.2 | KM Plot |
PCPG | rs4820671 | chr22:21275150 | A/C | 7.74E-5 | 177 | 12.57 | 31.68 | 25.2 | KM Plot |
PCPG | rs4820673 | chr22:21297960 | T/C | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |